These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34447895)

  • 1. Lack of Atorvastatin Effect on Monocyte Gene Expression and Inflammatory Markers in HIV-1-infected ART-suppressed Individuals at Risk of non-AIDS Comorbidities.
    Yadav A; Kossenkov AV; Showe LC; Ratcliffe SJ; Choi GH; Montaner LJ; Tebas P; Shaw PA; Collman RG
    Pathog Immun; 2021; 6(2):1-26. PubMed ID: 34447895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for Persistent Monocyte and Immune Dysregulation After Prolonged Viral Suppression Despite Normalization of Monocyte Subsets, sCD14 and sCD163 in HIV-Infected Individuals.
    Yadav A; Kossenkov AV; Knecht VR; Showe LC; Ratcliffe SJ; Montaner LJ; Tebas P; Collman RG
    Pathog Immun; 2019; 4(2):324-362. PubMed ID: 31893252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders.
    Yadav A; Betts MR; Collman RG
    J Neurovirol; 2016 Oct; 22(5):584-596. PubMed ID: 27021071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters.
    Iannetta M; Savinelli S; Rossi R; Mascia C; Marocco R; Vita S; Zuccalà P; Zingaropoli MA; Mengoni F; Massetti AP; Falciano M; d'Ettorre G; Ciardi MR; Mastroianni CM; Vullo V; Lichtner M
    Immunobiology; 2019 Mar; 224(2):231-241. PubMed ID: 30522891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of smoking with neurocognition, inflammatory and myeloid cell activation profiles in people with HIV on ART.
    Yadav A; Gionet G; Karaj A; Kossenkov AV; Kannan T; Putt ME; Stephens Shields AJ; Ashare RL; Collman RG
    AIDS; 2024 Sep; ():. PubMed ID: 39283742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy.
    McCausland MR; Juchnowski SM; Zidar DA; Kuritzkes DR; Andrade A; Sieg SF; Lederman MM; Funderburg NT
    PLoS One; 2015; 10(10):e0139474. PubMed ID: 26430882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.
    Kamat A; Misra V; Cassol E; Ancuta P; Yan Z; Li C; Morgello S; Gabuzda D
    PLoS One; 2012; 7(2):e30881. PubMed ID: 22363505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection.
    Naidoo KK; Ndumnego OC; Ismail N; Dong KL; Ndung'u T
    Front Immunol; 2021; 12():738743. PubMed ID: 34630420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.
    Funderburg NT; Jiang Y; Debanne SM; Storer N; Labbato D; Clagett B; Robinson J; Lederman MM; McComsey GA
    Clin Infect Dis; 2014 Feb; 58(4):588-95. PubMed ID: 24253250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.
    Tippett E; Cheng WJ; Westhorpe C; Cameron PU; Brew BJ; Lewin SR; Jaworowski A; Crowe SM
    PLoS One; 2011; 6(5):e19968. PubMed ID: 21625498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors.
    Prabhu VM; Singh AK; Padwal V; Nagar V; Patil P; Patel V
    Front Immunol; 2019; 10():2849. PubMed ID: 31867010
    [No Abstract]   [Full Text] [Related]  

  • 12. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection.
    Wilson EM; Singh A; Hullsiek KH; Gibson D; Henry WK; Lichtenstein K; Önen NF; Kojic E; Patel P; Brooks JT; Sereti I; Baker JV;
    J Infect Dis; 2014 Nov; 210(9):1396-406. PubMed ID: 24813472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?
    Castley A; Berry C; French M; Fernandez S; Krueger R; Nolan D
    PLoS One; 2014; 9(12):e115226. PubMed ID: 25544986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy.
    Yong YK; Shankar EM; Westhorpe CLV; Maisa A; Spelman T; Kamarulzaman A; Crowe SM; Lewin SR
    Medicine (Baltimore); 2016 Aug; 95(31):e4477. PubMed ID: 27495090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of CNS Viral Seeding by HIV
    Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Cognitive Performance and Reduced Monocyte Activation in Virally Suppressed Chronic HIV After Dual CCR2 and CCR5 Antagonism.
    DʼAntoni ML; Paul RH; Mitchell BI; Kohorn L; Fischer L; Lefebvre E; Seyedkazemi S; Nakamoto BK; Walker M; Kallianpur KJ; Ogata-Arakaki D; Ndhlovu LC; Shikuma C
    J Acquir Immune Defic Syndr; 2018 Sep; 79(1):108-116. PubMed ID: 29781885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children.
    Ananworanich J; Kerr SJ; Jaimulwong T; Vibol U; Hansudewechakul R; Kosalaraksa P; Ngampiyaskul C; Kanjanavanit S; Wongsawat J; Luesomboon W; Apornpong T; Soulas C; Paul R; Ruxrungtham K; Puthanakit T
    J Virus Erad; 2015; 1(3):196-202. PubMed ID: 26835517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.
    Hileman CO; Kinley B; Scharen-Guivel V; Melbourne K; Szwarcberg J; Robinson J; Lederman MM; Mccomsey GA
    J Infect Dis; 2015 Aug; 212(3):345-54. PubMed ID: 25583168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation.
    Patro SC; Azzoni L; Joseph J; Fair MG; Sierra-Madero JG; Rassool MS; Sanne I; Montaner LJ
    J Leukoc Biol; 2016 Jul; 100(1):223-31. PubMed ID: 26609048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.